SCHEMBL13611685

SCHEMBL13611685

CC(=O)CC1CCN(C(N)=O)CC1

nearest known ligand 0.46

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.43
TPSAB1 Q15661 1/20 0.37
TPSD1 Q9BZJ3 1/20 0.37
TPSG1 Q9NRR2 1/20 0.37
GAA P10253 1/20 0.37
NOS3 P29474 1/20 0.36
NOS2 P35228 1/20 0.36
ITGB3 P05106 6/20 0.35
ITGA2B P08514 6/20 0.35
NAMPT P43490 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.33
ALDH1A1 P00352 1/20 0.33
NPC1 O15118 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14433549 0.83 TPSAB1 (0.39) TPSAB1TPSD1TPSG1GAAITGB3
SCHEMBL10086273 0.83 AKR1C3 (0.46) AKR1C3SMN1; SMN2
SCHEMBL3904129 0.82 AKR1C3 (0.44) AKR1C3ITGB3ITGA2BNAMPTALDH1A1
SCHEMBL6179700 0.82 ITGB3 (0.45) ITGB3ITGA2B
SCHEMBL14266466 0.81 GAA (0.39) TPSAB1TPSD1TPSG1GAANOS3
SCHEMBL13604410 0.79 ITGB3 (0.39) TPSAB1TPSD1TPSG1GAAITGB3
SCHEMBL14255273 0.79 ITGB3 (0.37) TPSAB1TPSD1TPSG1GAAITGB3
SCHEMBL12669611 0.79 BRD4 (0.42) TPSAB1TPSD1TPSG1GAAITGB3
SCHEMBL13611708 0.79 AKR1C3 (0.39) AKR1C3NAMPTSMN1; SMN2ALDH1A1
SCHEMBL8280193 0.79 GAA (0.43) TPSAB1TPSD1TPSG1GAANOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015066515-A1 SELECTIVE SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS AND COMBINATION THERAPY THEREWITH RECEPTOS, INC. (US) 2015-05-07 WO disclosed
US-7635697-B2 Farnesyl protein transferase inhibitors and methods for treating proliferative diseases SCHERING CORPORATION (US) 2009-12-22 US disclosed
US-7342016-B2 Farnesyl protein transferase inhibitors as antitumor agents SCHERING CORPORATION (US) 2008-03-11 US disclosed
EP-1423381-B1 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREATMENT OF ANDROGEN DEPENDENT DISEASES SCHERING CORP (US) 2007-01-03 EP disclosed